Review



cell lines 293t cells atcc crl 3216 bhk 21 cells atcc ccl 10 oligonucleotides miniopterus ace2 point mutation primer s  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC cell lines 293t cells atcc crl 3216 bhk 21 cells atcc ccl 10 oligonucleotides miniopterus ace2 point mutation primer s
    Cell Lines 293t Cells Atcc Crl 3216 Bhk 21 Cells Atcc Ccl 10 Oligonucleotides Miniopterus Ace2 Point Mutation Primer S, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 5298 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/BHK-21/pm42876586-161-15-19
    Average 99 stars, based on 5298 article reviews
    cell lines 293t cells atcc crl 3216 bhk 21 cells atcc ccl 10 oligonucleotides miniopterus ace2 point mutation primer s - by Bioz Stars, 2026-11
    99/100 stars

    Images

    Related Articles

    Expressing:

    Article Title: New insights into how popular electronic cigarette aerosols and aerosol constituents affect SARS-CoV-2 infection of human bronchial epithelial cells
    Article Snippet: .. HEK 293T cells (ATCC, Manassas, VA, USA), and HEK 293T cells over expressing ACE2 (HEK 293T ACE2 , BEI resource, Manassas, VA, USA; NR-52511) were cultured in DMEM high glucose medium supplemented with 10% fetal bovine serum (FBS; ATCC Manassas, VA, USA). ..

    Article Title: A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.
    Article Snippet: .. Anti-SARS-CoV-2 activity assay for carvedilol A549 (CCL-185; ATCC) cells exogenously expressing ACE2 (A549-ACE2) were a gift from B. R. Tenoever, Icahn School of Medicine at Mount Sinai. .. A549-ACE2 cells were cultured in DMEM (catalog no. 11965092; ThermoFisher) with 10% FBS (catalog no. 100–106; GeminiBio) and used for SARS-CoV-2 infection.

    Article Title: A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets
    Article Snippet: .. A549 (CCL-185; ATCC) cells exogenously expressing ACE2 (A549-ACE2) were a gift from B. R. Tenoever, Icahn School of Medicine at Mount Sinai. .. A549-ACE2 cells were cultured in DMEM (catalog no. 11965092; ThermoFisher) with 10% FBS (catalog no. 100–106; GeminiBio) and used for SARS-CoV-2 infection.

    Cell Culture:

    Article Title: New insights into how popular electronic cigarette aerosols and aerosol constituents affect SARS-CoV-2 infection of human bronchial epithelial cells
    Article Snippet: .. HEK 293T cells (ATCC, Manassas, VA, USA), and HEK 293T cells over expressing ACE2 (HEK 293T ACE2 , BEI resource, Manassas, VA, USA; NR-52511) were cultured in DMEM high glucose medium supplemented with 10% fetal bovine serum (FBS; ATCC Manassas, VA, USA). ..

    Article Title: High-throughput screening identifies broad-spectrum Coronavirus entry inhibitors
    Article Snippet: Baby Hamster Kidney cells (BHK-21; ATCC, USA) were maintained in Dulbecco’s modified eagle medium (DMEM; Thermo Fisher Scientific, USA) supplemented with 10% fetal bovine serum (FBS; Thermo Fisher Scientific), 1% penicillin-streptomycin (PS, Biological Industries) and 25mM HEPES (Biological Industries). .. Human Embryonic Kidney-293T cells (HEK-293T; ATCC), HEK-293T overexpressing either ACE2 (HEK-293T-ACE2) or both ACE2 and TMPRSS2 (HEK-293T-ACE2-TMPRSS2), or ACE2, DPP4 and TMPRSS2 (HEK-293T-ACE2-TMPRSS2-DPP4) were cultured in DMEM supplemented with 8.1% FBS, 1% PS, 25mM HEPES. .. Baby Hamster Kidney cells (BHK-21; ATCC, USA) were maintained in Dulbecco’s modified eagle medium (DMEM; Thermo Fisher Scientific, USA) supplemented with 10% fetal bovine serum (FBS; Thermo Fisher Scientific), 1% penicillin-streptomycin (PS, Biological Industries) and 25mM HEPES (Biological Industries).

    other:

    Article Title: High-throughput screening identifies broad-spectrum Coronavirus entry inhibitors.
    Article Snippet: (Technion - Israel Institute of Technology) https://doi.org/10.1126/ science.1202333 pCG1-SARS2-Spike-HA Prof. Gideon Schreiber (Weizmann Institute of Science) NA pCMV3-SARS2-Spike-Flag Prof. Gideon Schreiber (Weizmann Institute of Science) NA pCMV3-SARS2-SpikeD19 Prof. Yosef Shaul (Weizmann Institute of Science) https://doi.org/10.1038/ s41598-022-09664-1 pCMV3-SARS2-SpikeD19-Flag Prof. Yosef Shaul (Weizmann Institute of Science) https://doi.org/10.1038/ s41598-022-09664-1 pcDNA3.1-SARS-CoV-2-Spike-C9 Addgene Cat# 145032 pcDNA3.1-SARS-CoV-2-Sa-C9 This paper NA (Continued on next page) iScience 27, 110019, June 21, 2024 15

    Article Title: High throughput screening identifies broad-spectrum Coronavirus entry inhibitors
    Article Snippet: pcDNA3.1-SARS-CoV-2-S α , SARS-CoV-2-S δ , and SARS-CoV-2-S ο, encoding the Spike glycoprotein of Wuhan SARS-CoV-2 variants fused to a C-terminal C9 tag were generated by DNA synthesis (GeneScript).

    Modification:

    Article Title: A Novel Toolkit of SARS-CoV-2 Sub-Genomic Replicons for Efficient Antiviral Screening
    Article Snippet: .. A human bronchial epithelium cell line BEAS-2B (ATCC CRL-3588TM) modified to express ACE2 (BEAS-2BA/ACE2 (BEAS-2BA)) was a kind gift from Prof Stuart Neil and Dr Harry Wilson, King’s College London. .. All cells were maintained in Dulbecco’s Modified Eagle’s medium, containing 4.5 g/L D-glucose, and GlutaMAXTM (DMEM, GibcoTM, Thermo Fisher Scientific) supplemented with 1 mM sodium pyruvate (Sigma-Aldrich) and 10% ( v / v ) foetal bovine serum (FBS, GibcoTM, Thermo Fisher Scientific), except for Caco-2N and Calu-3 cells, which were maintained in Eagle’s Minimal Essential medium containing GlutaMAXTM (MEM, GibcoTM, Thermo Fisher Scientific) supplemented with 1 mM sodium pyruvate (Sigma-Aldrich), 10% ( v / v ) FBS and 0.1 mM non-essential amino acids (GibcoTM, Thermo Fisher Scientific).

    Article Title: A Novel Toolkit of SARS-CoV-2 Sub-Genomic Replicons for Efficient Antiviral Screening.
    Article Snippet: .. A human bronchial epithelium cell line BEAS-2B (ATCC CRL-3588TM) modified to express ACE2 (BEAS-2BA/ACE2 (BEAS-2BA)) was a kind gift from Prof Stuart Neil and Dr Harry Wilson, King’s College London. .. All cells were maintained in Dulbecco’s Modified Eagle’s medium, containing 4.5 g/L D-glucose, and GlutaMAXTM (DMEM, GibcoTM, Thermo Fisher Scientific) supplemented with 1 mM sodium pyruvate (Sigma-Aldrich) and 10% (v/v) foetal bovine serum (FBS, GibcoTM, Thermo Fisher Scientific), except for Caco-2N and Calu-3 cells, which were maintained in Eagle’s Minimal Essential medium containing GlutaMAXTM (MEM, GibcoTM, Thermo Fisher Scientific) supplemented with 1 mM sodium pyruvate (Sigma-Aldrich), 10% (v/v) FBS and 0.1 mM non-essential amino acids (GibcoTM, Thermo Fisher Scientific).

    Activity Assay:

    Article Title: A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.
    Article Snippet: .. Anti-SARS-CoV-2 activity assay for carvedilol A549 (CCL-185; ATCC) cells exogenously expressing ACE2 (A549-ACE2) were a gift from B. R. Tenoever, Icahn School of Medicine at Mount Sinai. .. A549-ACE2 cells were cultured in DMEM (catalog no. 11965092; ThermoFisher) with 10% FBS (catalog no. 100–106; GeminiBio) and used for SARS-CoV-2 infection.



    Similar Products

    92
    AMS Biotechnology ace2: spike s1 rbd (sars-cov-2) inhibitor screening assay kit
    Ace2: Spike S1 Rbd (Sars Cov 2) Inhibitor Screening Assay Kit, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/ACE2%3A+Spike+S1+RBD+(SARS-CoV-2)+Inhibitor+Screening+Assay+Kit/custom%4079936%4042744080
    Average 92 stars, based on 1 article reviews
    ace2: spike s1 rbd (sars-cov-2) inhibitor screening assay kit - by Bioz Stars, 2026-11
    92/100 stars
      Buy from Supplier

    94
    Shanghai Korain Biotech Co Ltd ace2 activity assay kit
    Ace2 Activity Assay Kit, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/Rat+Angiotensin+Converting+Enzyme+2/pm42908280-92-49-68
    Average 94 stars, based on 1 article reviews
    ace2 activity assay kit - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    95
    ACROBiosystems biotinylated human ace2
    Biotinylated Human Ace2, supplied by ACROBiosystems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/Biotinylated+Human+ACE2+%2F+ACEH+Protein%2C+His%2CAvitag/pm42913748-100-15-21
    Average 95 stars, based on 1 article reviews
    biotinylated human ace2 - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    94
    Proteintech ace2
    Ace2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/ACE2+Polyclonal+antibody/pm42892631-104-16-17
    Average 94 stars, based on 1 article reviews
    ace2 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    ATCC cell lines 293t cells atcc crl 3216 bhk 21 cells atcc ccl 10 oligonucleotides miniopterus ace2 point mutation primer s
    Cell Lines 293t Cells Atcc Crl 3216 Bhk 21 Cells Atcc Ccl 10 Oligonucleotides Miniopterus Ace2 Point Mutation Primer S, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/BHK-21/pm42876586-161-15-19
    Average 99 stars, based on 1 article reviews
    cell lines 293t cells atcc crl 3216 bhk 21 cells atcc ccl 10 oligonucleotides miniopterus ace2 point mutation primer s - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology ace2
    Binding of eCypA to TβR2 facilitates the formation of the TGFβ1‐TGF‐β receptor 2 complex (A) qPCR analysis of ITGA5 and FN mRNA levels in A549 cells transfected with siRNAs targeting TβR2, CD147, <t>ACE2,</t> or MUC18 for 48 h, and then treated with 10 nM eCypA or PBS for 12 h. (B) Immunoblot analysis of the indicated proteins in immunoprecipitated samples and whole‐cell lysates (WCL) of A549 cells treated with Fc, CypA‐Fc (200 ng/mL), R55‐Fc (200 ng/mL), CypA‐Fc + anti‐CypA mAb (1 µg/mL), or R55‐Fc + anti‐CypA mAb for 2 h. (C) Interactions of CypA with TGF‐β1, TβR1, and TβR2 were detected using ELISA. BSA was used as a negative control. (D) The blocking effect of the anti‐CypA mAb on the binding of CypA to TβR2 was detected using ELISA. (E–H) Interaction of CypA with anti‐CypA mAb (E) and TβR2 (F) was detected by SPR. The competitive effect of anti‐CypA mAb on CypA‐TβR2 interaction was detected using competitive SPR assay (G). Linearities of the CypA‐TβR2 interaction were generated from the data of the sampling points shown in (H). (I) Immunoblot analysis of the indicated proteins in A549 cells treated with eCypA (10 nM) or eCypA (10 nM) + TGF‐β pAb (50 nM) for 30 min. (J) Adherence assays of GAS in A549 cells treated with eCypA (10 nM) or eCypA (10 nM) + TGF‐β pAb (50 nM) for 12 h, and then infected with GAS (MOI = 10.0) for 2 h. Data are reported as the percentage of adherent bacteria relative to the input inoculum. (K) Immunoblot analysis of the indicated proteins in immunoprecipitated samples and WCLs of A549 cells treated with TGF‐β1 (5 ng/mL), TGF‐β1 + CypA‐His (10 nM), or TGF‐β1 + CypA‐His + anti‐CypA mAb (50 nM) for 2 h. (L and M) Interactions of TGF‐β1 with TβR2 were detected by SPR in the absence (L) or presence (M) of CypA. Data are presented as the means ± SDs; ** p < 0.01, *** p < 0.001 and ns = not significant; unpaired two‐tailed Student's t test for (D); one‐way ANOVA followed by Dunnett's test for (A) and (J).
    Ace2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/ACE2+siRNA/pmc13659286-221-5-9
    Average 94 stars, based on 1 article reviews
    ace2 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology ace2 rabbit pab
    Representative figures of protein expression and localisation of <t>ACE2,</t> CD147/basigin, EGFR and LDLR as determined by immunohistochemistry. The left panel shows the protein expression level in control group and the right panel shows receptor protein expression changes in pregnant women with high exposure risk to SARS-CoV-2.
    Ace2 Rabbit Pab, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/ACE2+Rabbit+pAb/bio_rxiv__64898__2026__10__08__757814-71-17-20
    Average 94 stars, based on 1 article reviews
    ace2 rabbit pab - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    Kyfora Bio japanese horseshoe bat ace2
    A) Binding of IgG and Fab to recombinant RBDs of Sarbecoviruses from different clades by ELISA <t>including</t> <t>SARS-CoV-2</t> (clade 1b), WIV-1 (clade 1a), Rs4321 (clade 1a), RacCS203 (clade 2), Rc-o319 (clade 5), and RhGB07 (clade 3). Experiments were run in duplicate and repeated twice. A representative assay is shown. Fab binding is shown with the dotted line and IgG binding with the full line. B) Neutralising activity of IgGs against SARS-CoV-2 and variants of concern as well as SARS-CoV-1 and WIV-1. C) IC 50 values for neutralisation against SARS-CoV-2 variants of concern and other sarbecoviruses that utilise <t>human-ACE2.</t> For A–C, the mean value is plotted with error bars showing ± standard deviation (s.d.). D) Ability of IgGs to inhibit the interaction between cell surface human ACE2 and soluble SARS-CoV-2 and WIV-1 RBDs. IgGs were pre-incubated with fluorescently labelled RBD before addition to HeLa-ACE2 cells. The percentage reduction in mean fluorescence intensity is reported. Experiments were performed in duplicate. E) Superimposed 3D structures of the V1WT_06 (dark blue), V1WT_41 (purple), and VA14_26 (red) around WIV-1 RBD (light blue, from PDB 8WLZ). The data underlying this Figure can be found in .
    Japanese Horseshoe Bat Ace2, supplied by Kyfora Bio, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/PEI+MAX+Transfection+Reagent/pmc13630248-206-9-18
    Average 99 stars, based on 1 article reviews
    japanese horseshoe bat ace2 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Kyfora Bio pei max transfection reagent
    A) Binding of IgG and Fab to recombinant RBDs of Sarbecoviruses from different clades by ELISA <t>including</t> <t>SARS-CoV-2</t> (clade 1b), WIV-1 (clade 1a), Rs4321 (clade 1a), RacCS203 (clade 2), Rc-o319 (clade 5), and RhGB07 (clade 3). Experiments were run in duplicate and repeated twice. A representative assay is shown. Fab binding is shown with the dotted line and IgG binding with the full line. B) Neutralising activity of IgGs against SARS-CoV-2 and variants of concern as well as SARS-CoV-1 and WIV-1. C) IC 50 values for neutralisation against SARS-CoV-2 variants of concern and other sarbecoviruses that utilise <t>human-ACE2.</t> For A–C, the mean value is plotted with error bars showing ± standard deviation (s.d.). D) Ability of IgGs to inhibit the interaction between cell surface human ACE2 and soluble SARS-CoV-2 and WIV-1 RBDs. IgGs were pre-incubated with fluorescently labelled RBD before addition to HeLa-ACE2 cells. The percentage reduction in mean fluorescence intensity is reported. Experiments were performed in duplicate. E) Superimposed 3D structures of the V1WT_06 (dark blue), V1WT_41 (purple), and VA14_26 (red) around WIV-1 RBD (light blue, from PDB 8WLZ). The data underlying this Figure can be found in .
    Pei Max Transfection Reagent, supplied by Kyfora Bio, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ace2/PEI+MAX+Transfection+Reagent/custom%4024765-1%4042748909
    Average 99 stars, based on 1 article reviews
    pei max transfection reagent - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    Binding of eCypA to TβR2 facilitates the formation of the TGFβ1‐TGF‐β receptor 2 complex (A) qPCR analysis of ITGA5 and FN mRNA levels in A549 cells transfected with siRNAs targeting TβR2, CD147, ACE2, or MUC18 for 48 h, and then treated with 10 nM eCypA or PBS for 12 h. (B) Immunoblot analysis of the indicated proteins in immunoprecipitated samples and whole‐cell lysates (WCL) of A549 cells treated with Fc, CypA‐Fc (200 ng/mL), R55‐Fc (200 ng/mL), CypA‐Fc + anti‐CypA mAb (1 µg/mL), or R55‐Fc + anti‐CypA mAb for 2 h. (C) Interactions of CypA with TGF‐β1, TβR1, and TβR2 were detected using ELISA. BSA was used as a negative control. (D) The blocking effect of the anti‐CypA mAb on the binding of CypA to TβR2 was detected using ELISA. (E–H) Interaction of CypA with anti‐CypA mAb (E) and TβR2 (F) was detected by SPR. The competitive effect of anti‐CypA mAb on CypA‐TβR2 interaction was detected using competitive SPR assay (G). Linearities of the CypA‐TβR2 interaction were generated from the data of the sampling points shown in (H). (I) Immunoblot analysis of the indicated proteins in A549 cells treated with eCypA (10 nM) or eCypA (10 nM) + TGF‐β pAb (50 nM) for 30 min. (J) Adherence assays of GAS in A549 cells treated with eCypA (10 nM) or eCypA (10 nM) + TGF‐β pAb (50 nM) for 12 h, and then infected with GAS (MOI = 10.0) for 2 h. Data are reported as the percentage of adherent bacteria relative to the input inoculum. (K) Immunoblot analysis of the indicated proteins in immunoprecipitated samples and WCLs of A549 cells treated with TGF‐β1 (5 ng/mL), TGF‐β1 + CypA‐His (10 nM), or TGF‐β1 + CypA‐His + anti‐CypA mAb (50 nM) for 2 h. (L and M) Interactions of TGF‐β1 with TβR2 were detected by SPR in the absence (L) or presence (M) of CypA. Data are presented as the means ± SDs; ** p < 0.01, *** p < 0.001 and ns = not significant; unpaired two‐tailed Student's t test for (D); one‐way ANOVA followed by Dunnett's test for (A) and (J).

    Journal: MedComm

    Article Title: Blocking Extracellular Cyclophilin A‐Mediated Adhesion Protects Against Bacterial Infection

    doi: 10.1002/mco2.71063

    Figure Lengend Snippet: Binding of eCypA to TβR2 facilitates the formation of the TGFβ1‐TGF‐β receptor 2 complex (A) qPCR analysis of ITGA5 and FN mRNA levels in A549 cells transfected with siRNAs targeting TβR2, CD147, ACE2, or MUC18 for 48 h, and then treated with 10 nM eCypA or PBS for 12 h. (B) Immunoblot analysis of the indicated proteins in immunoprecipitated samples and whole‐cell lysates (WCL) of A549 cells treated with Fc, CypA‐Fc (200 ng/mL), R55‐Fc (200 ng/mL), CypA‐Fc + anti‐CypA mAb (1 µg/mL), or R55‐Fc + anti‐CypA mAb for 2 h. (C) Interactions of CypA with TGF‐β1, TβR1, and TβR2 were detected using ELISA. BSA was used as a negative control. (D) The blocking effect of the anti‐CypA mAb on the binding of CypA to TβR2 was detected using ELISA. (E–H) Interaction of CypA with anti‐CypA mAb (E) and TβR2 (F) was detected by SPR. The competitive effect of anti‐CypA mAb on CypA‐TβR2 interaction was detected using competitive SPR assay (G). Linearities of the CypA‐TβR2 interaction were generated from the data of the sampling points shown in (H). (I) Immunoblot analysis of the indicated proteins in A549 cells treated with eCypA (10 nM) or eCypA (10 nM) + TGF‐β pAb (50 nM) for 30 min. (J) Adherence assays of GAS in A549 cells treated with eCypA (10 nM) or eCypA (10 nM) + TGF‐β pAb (50 nM) for 12 h, and then infected with GAS (MOI = 10.0) for 2 h. Data are reported as the percentage of adherent bacteria relative to the input inoculum. (K) Immunoblot analysis of the indicated proteins in immunoprecipitated samples and WCLs of A549 cells treated with TGF‐β1 (5 ng/mL), TGF‐β1 + CypA‐His (10 nM), or TGF‐β1 + CypA‐His + anti‐CypA mAb (50 nM) for 2 h. (L and M) Interactions of TGF‐β1 with TβR2 were detected by SPR in the absence (L) or presence (M) of CypA. Data are presented as the means ± SDs; ** p < 0.01, *** p < 0.001 and ns = not significant; unpaired two‐tailed Student's t test for (D); one‐way ANOVA followed by Dunnett's test for (A) and (J).

    Article Snippet: Moreover, siRNAs targeting TGFBR2 and ACE2 were purchased from Santa Cruz Biotechnology.

    Techniques: Binding Assay, Analysis, Transfection, Western Blot, Immunoprecipitation, Enzyme-linked Immunosorbent Assay, Negative Control, Blocking Assay, SPR Assay, Generated, Sampling, Infection, Bacteria, Two Tailed Test

    Representative figures of protein expression and localisation of ACE2, CD147/basigin, EGFR and LDLR as determined by immunohistochemistry. The left panel shows the protein expression level in control group and the right panel shows receptor protein expression changes in pregnant women with high exposure risk to SARS-CoV-2.

    Journal: bioRxiv

    Article Title: Non-canonical alternate interactors of SARS CoV-2 Spike protein implicated in placental susceptibilty

    doi: 10.64898/2026.10.08.757814

    Figure Lengend Snippet: Representative figures of protein expression and localisation of ACE2, CD147/basigin, EGFR and LDLR as determined by immunohistochemistry. The left panel shows the protein expression level in control group and the right panel shows receptor protein expression changes in pregnant women with high exposure risk to SARS-CoV-2.

    Article Snippet: This was followed by incubation with primary antibodies-CD147 Rabbit pAb, EGFR Rabbit pAb, LDLR Rabbit pAb and ACE2 Rabbit pAb (ABclonal, 1:200) overnight at 4°C.

    Techniques: Expressing, Immunohistochemistry, Control

    Protein expression (by quantification of IHC) and mRNA expression (by qRT-PCR) of (A) ACE2 (B) CD147/basigin (C) EGFR (D) LDLR in placental samples obtained from control women and those with exposure risk to COVID during pregnancy. Blue triangles indicate mRNA expression; red dots indicate the corresponding protein expression.

    Journal: bioRxiv

    Article Title: Non-canonical alternate interactors of SARS CoV-2 Spike protein implicated in placental susceptibilty

    doi: 10.64898/2026.10.08.757814

    Figure Lengend Snippet: Protein expression (by quantification of IHC) and mRNA expression (by qRT-PCR) of (A) ACE2 (B) CD147/basigin (C) EGFR (D) LDLR in placental samples obtained from control women and those with exposure risk to COVID during pregnancy. Blue triangles indicate mRNA expression; red dots indicate the corresponding protein expression.

    Article Snippet: This was followed by incubation with primary antibodies-CD147 Rabbit pAb, EGFR Rabbit pAb, LDLR Rabbit pAb and ACE2 Rabbit pAb (ABclonal, 1:200) overnight at 4°C.

    Techniques: Expressing, Quantitative RT-PCR, Control

    A) Binding of IgG and Fab to recombinant RBDs of Sarbecoviruses from different clades by ELISA including SARS-CoV-2 (clade 1b), WIV-1 (clade 1a), Rs4321 (clade 1a), RacCS203 (clade 2), Rc-o319 (clade 5), and RhGB07 (clade 3). Experiments were run in duplicate and repeated twice. A representative assay is shown. Fab binding is shown with the dotted line and IgG binding with the full line. B) Neutralising activity of IgGs against SARS-CoV-2 and variants of concern as well as SARS-CoV-1 and WIV-1. C) IC 50 values for neutralisation against SARS-CoV-2 variants of concern and other sarbecoviruses that utilise human-ACE2. For A–C, the mean value is plotted with error bars showing ± standard deviation (s.d.). D) Ability of IgGs to inhibit the interaction between cell surface human ACE2 and soluble SARS-CoV-2 and WIV-1 RBDs. IgGs were pre-incubated with fluorescently labelled RBD before addition to HeLa-ACE2 cells. The percentage reduction in mean fluorescence intensity is reported. Experiments were performed in duplicate. E) Superimposed 3D structures of the V1WT_06 (dark blue), V1WT_41 (purple), and VA14_26 (red) around WIV-1 RBD (light blue, from PDB 8WLZ). The data underlying this Figure can be found in .

    Journal: PLOS Biology

    Article Title: Targeting of conserved spike epitopes enables broad antibody neutralisation of diverse bat sarbecoviruses

    doi: 10.1371/journal.pbio.3003882

    Figure Lengend Snippet: A) Binding of IgG and Fab to recombinant RBDs of Sarbecoviruses from different clades by ELISA including SARS-CoV-2 (clade 1b), WIV-1 (clade 1a), Rs4321 (clade 1a), RacCS203 (clade 2), Rc-o319 (clade 5), and RhGB07 (clade 3). Experiments were run in duplicate and repeated twice. A representative assay is shown. Fab binding is shown with the dotted line and IgG binding with the full line. B) Neutralising activity of IgGs against SARS-CoV-2 and variants of concern as well as SARS-CoV-1 and WIV-1. C) IC 50 values for neutralisation against SARS-CoV-2 variants of concern and other sarbecoviruses that utilise human-ACE2. For A–C, the mean value is plotted with error bars showing ± standard deviation (s.d.). D) Ability of IgGs to inhibit the interaction between cell surface human ACE2 and soluble SARS-CoV-2 and WIV-1 RBDs. IgGs were pre-incubated with fluorescently labelled RBD before addition to HeLa-ACE2 cells. The percentage reduction in mean fluorescence intensity is reported. Experiments were performed in duplicate. E) Superimposed 3D structures of the V1WT_06 (dark blue), V1WT_41 (purple), and VA14_26 (red) around WIV-1 RBD (light blue, from PDB 8WLZ). The data underlying this Figure can be found in .

    Article Snippet: HEK293T cells were transfected with either Human, Halcyon or Japanese horseshoe bat ACE2 using PEI Max (1 mg/mL, Polysciences) at 3:1, 6:1, and 2:1 ratio (PEI Max:DNA), respectively.

    Techniques: Binding Assay, Recombinant, Enzyme-linked Immunosorbent Assay, Activity Assay, Standard Deviation, Incubation, Fluorescence

    A) A closeup view of the superimposed structure of V1WT_06 bound to WIV-1 RBD on a trimeric spike (from PDB: 8WLZ). A clash with NTD of chain B is observed when V1WT_06 Fab-RBD complex is aligned onto RBD in the up conformation (chain A) in trimeric WIV-1 spike protein. Notably, the binding site is inaccessible in the RBD-down conformation. B) V1WT_06 heavy chain only interaction with WIV-1 RBD (grey). Heavy and light chains are shown with the dark and light blue ribbons, respectively. C) V1WT_06 epitope footprint overlayed with epitope footprints of other site V neutralising antibodies including S2H97, CC25.4, 5817, R1-32, and E465 patch [ , – , ]. SARS-CoV-2 RBD (from PDB: 6m0j) is coloured based on the amino acid conservation across 87 bat sarbecoviruses [ , , , ]. D) Sequence alignment of a panel of bat sarbecovirus RBDs. Contact residues of V1WT_06 mAb on the WIV-1-RBD are indicated with black dots. The colouring scheme describes the percent identity (PID) between the sequences as implemented in Jalview 2.11.4.0. E) Comparison in neutralisation potency of V1WT_06 Fab and IgG against SARS-CoV-2 (D614G), SARS-CoV-1, and WIV-1. Mean values are plotted with error bars showing ± standard deviation (s.d.). The data underlying this Figure can be found in .

    Journal: PLOS Biology

    Article Title: Targeting of conserved spike epitopes enables broad antibody neutralisation of diverse bat sarbecoviruses

    doi: 10.1371/journal.pbio.3003882

    Figure Lengend Snippet: A) A closeup view of the superimposed structure of V1WT_06 bound to WIV-1 RBD on a trimeric spike (from PDB: 8WLZ). A clash with NTD of chain B is observed when V1WT_06 Fab-RBD complex is aligned onto RBD in the up conformation (chain A) in trimeric WIV-1 spike protein. Notably, the binding site is inaccessible in the RBD-down conformation. B) V1WT_06 heavy chain only interaction with WIV-1 RBD (grey). Heavy and light chains are shown with the dark and light blue ribbons, respectively. C) V1WT_06 epitope footprint overlayed with epitope footprints of other site V neutralising antibodies including S2H97, CC25.4, 5817, R1-32, and E465 patch [ , – , ]. SARS-CoV-2 RBD (from PDB: 6m0j) is coloured based on the amino acid conservation across 87 bat sarbecoviruses [ , , , ]. D) Sequence alignment of a panel of bat sarbecovirus RBDs. Contact residues of V1WT_06 mAb on the WIV-1-RBD are indicated with black dots. The colouring scheme describes the percent identity (PID) between the sequences as implemented in Jalview 2.11.4.0. E) Comparison in neutralisation potency of V1WT_06 Fab and IgG against SARS-CoV-2 (D614G), SARS-CoV-1, and WIV-1. Mean values are plotted with error bars showing ± standard deviation (s.d.). The data underlying this Figure can be found in .

    Article Snippet: HEK293T cells were transfected with either Human, Halcyon or Japanese horseshoe bat ACE2 using PEI Max (1 mg/mL, Polysciences) at 3:1, 6:1, and 2:1 ratio (PEI Max:DNA), respectively.

    Techniques: Binding Assay, Sequencing, Comparison, Standard Deviation

    A) VA14_26 and V1WT_41 antibody footprints overlayed with the epitope footprints of other RBD class 4 neutralising antibodies including CR3022, 10−40, ADI-62113 [ – ]. SARS-CoV-2 RBD (from PDB: 6m0j) is coloured based on the amino acid conservation across 87 bat sarbecoviruses [ , , , ]. B) Superimposed 3D structure depicting the binding of VA14_26 (Red) to WIV-1 RBD (blue) in relation to ACE2 (orange, from PDB: 8WLZ) and CR3022 (pink, from PDB: 6W41). C) Superimposed 3D structure depicting the binding of V1WT_41 (green) to WIV-1 RBD (blue) in relation to ACE2 (orange, from PDB: 8WLZ). D) Sequence alignment of a panel of bat sarbecovirus RBDs. Contact residues for VA14_26 and V1WT_41 are indicated by red and pink dots and outline, respectively. Shared contact residues are shown with yellow dots and outline. E) Sequence alignment of a panel of SARS-CoV-2 variant RBDs. Contact residues for VA14_26 and V1WT_41 are indicated by red and pink dots and outline, respectively. Shared contact residues are shown with yellow dots and outline. The colouring scheme describes the percent identity (PID) between the sequences as implemented in Jalview 2.11.4.0. F) A close-up view of YYDRSG motif in V1WT_41 HCDR3 (green) in contact with WIV-1 RBD (grey), shown in stick representation, renumbered based on alignment to SARS-CoV-2 [ , ]. Presence of G109 breaks the H-bonding pattern in the beta hairpin to create a G1 β-bulge. This further enables D106 side chain to make hydrogen bond with the amides in the protein backbone, thereby stabilising the local structure. Combined this accentuates a right-handed twist found in G1 β-bulge . Twisting of the β-hairpin is thought to contribute towards stabilisation of RBD-Fab interaction in several other public mAbs with YYDRxG motif [ , ].

    Journal: PLOS Biology

    Article Title: Targeting of conserved spike epitopes enables broad antibody neutralisation of diverse bat sarbecoviruses

    doi: 10.1371/journal.pbio.3003882

    Figure Lengend Snippet: A) VA14_26 and V1WT_41 antibody footprints overlayed with the epitope footprints of other RBD class 4 neutralising antibodies including CR3022, 10−40, ADI-62113 [ – ]. SARS-CoV-2 RBD (from PDB: 6m0j) is coloured based on the amino acid conservation across 87 bat sarbecoviruses [ , , , ]. B) Superimposed 3D structure depicting the binding of VA14_26 (Red) to WIV-1 RBD (blue) in relation to ACE2 (orange, from PDB: 8WLZ) and CR3022 (pink, from PDB: 6W41). C) Superimposed 3D structure depicting the binding of V1WT_41 (green) to WIV-1 RBD (blue) in relation to ACE2 (orange, from PDB: 8WLZ). D) Sequence alignment of a panel of bat sarbecovirus RBDs. Contact residues for VA14_26 and V1WT_41 are indicated by red and pink dots and outline, respectively. Shared contact residues are shown with yellow dots and outline. E) Sequence alignment of a panel of SARS-CoV-2 variant RBDs. Contact residues for VA14_26 and V1WT_41 are indicated by red and pink dots and outline, respectively. Shared contact residues are shown with yellow dots and outline. The colouring scheme describes the percent identity (PID) between the sequences as implemented in Jalview 2.11.4.0. F) A close-up view of YYDRSG motif in V1WT_41 HCDR3 (green) in contact with WIV-1 RBD (grey), shown in stick representation, renumbered based on alignment to SARS-CoV-2 [ , ]. Presence of G109 breaks the H-bonding pattern in the beta hairpin to create a G1 β-bulge. This further enables D106 side chain to make hydrogen bond with the amides in the protein backbone, thereby stabilising the local structure. Combined this accentuates a right-handed twist found in G1 β-bulge . Twisting of the β-hairpin is thought to contribute towards stabilisation of RBD-Fab interaction in several other public mAbs with YYDRxG motif [ , ].

    Article Snippet: HEK293T cells were transfected with either Human, Halcyon or Japanese horseshoe bat ACE2 using PEI Max (1 mg/mL, Polysciences) at 3:1, 6:1, and 2:1 ratio (PEI Max:DNA), respectively.

    Techniques: Binding Assay, Sequencing, Variant Assay

    Neutralisation of sarbecoviruses through entry via different host ACE2s. Neutralisation of A) Rc-o319 and B) RhGB07 was measured against entry via Rh. cornutus ACE2 and Rh. alcyone ACE2, respectively, which were transiently expressed in HEK293T/17 cells. C) Neutralisation of WIV-1 was compared between entry via hu-ACE2 (dotted line and closed symbols) and Rh. alcyone ACE2 (full line and closed symbols). Neutralisation was measured using HEK 293T cells transiently expressing either Human ACE2 or Rh. alcyone ACE2. For A-C, mean values are plotted with error bars showing ± standard deviation (s.d.). D) Ability of IgGs to inhibit the interaction between cell surface ACE2 (including hu-ACE2, Rh. cornutus ACE2 and Rh. alcyone ACE2) and soluble RBD (including SARS-CoV-2, WIV-1, Rs4231, RhBG07, and Rc-o319 RBDs). IgGs were pre-incubated with fluorescently labelled RBD before addition to ACE2 expressing cells. N.B = No binding of IgG to the RBD. The percentage reduction in mean fluorescence intensity is reported. Experiments were performed in duplicate. E) Antibody dependant cellular cytotoxicity (ADCC) of IgGs measured through the surface expression of CD107a on activated NK cells (NK-92 cells expressing CD16) . HIV-1 specific neutralising antibody, PGT128 is used as a negative control . The data underlying this Figure can be found in .

    Journal: PLOS Biology

    Article Title: Targeting of conserved spike epitopes enables broad antibody neutralisation of diverse bat sarbecoviruses

    doi: 10.1371/journal.pbio.3003882

    Figure Lengend Snippet: Neutralisation of sarbecoviruses through entry via different host ACE2s. Neutralisation of A) Rc-o319 and B) RhGB07 was measured against entry via Rh. cornutus ACE2 and Rh. alcyone ACE2, respectively, which were transiently expressed in HEK293T/17 cells. C) Neutralisation of WIV-1 was compared between entry via hu-ACE2 (dotted line and closed symbols) and Rh. alcyone ACE2 (full line and closed symbols). Neutralisation was measured using HEK 293T cells transiently expressing either Human ACE2 or Rh. alcyone ACE2. For A-C, mean values are plotted with error bars showing ± standard deviation (s.d.). D) Ability of IgGs to inhibit the interaction between cell surface ACE2 (including hu-ACE2, Rh. cornutus ACE2 and Rh. alcyone ACE2) and soluble RBD (including SARS-CoV-2, WIV-1, Rs4231, RhBG07, and Rc-o319 RBDs). IgGs were pre-incubated with fluorescently labelled RBD before addition to ACE2 expressing cells. N.B = No binding of IgG to the RBD. The percentage reduction in mean fluorescence intensity is reported. Experiments were performed in duplicate. E) Antibody dependant cellular cytotoxicity (ADCC) of IgGs measured through the surface expression of CD107a on activated NK cells (NK-92 cells expressing CD16) . HIV-1 specific neutralising antibody, PGT128 is used as a negative control . The data underlying this Figure can be found in .

    Article Snippet: HEK293T cells were transfected with either Human, Halcyon or Japanese horseshoe bat ACE2 using PEI Max (1 mg/mL, Polysciences) at 3:1, 6:1, and 2:1 ratio (PEI Max:DNA), respectively.

    Techniques: Expressing, Standard Deviation, Incubation, Binding Assay, Fluorescence, Negative Control